These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23522977)

  • 1. [¹¹C]Sorafenib: radiosynthesis and preclinical evaluation in tumor-bearing mice of a new TKI-PET tracer.
    Poot AJ; van der Wildt B; Stigter-van Walsum M; Rongen M; Schuit RC; Hendrikse NH; Eriksson J; van Dongen GA; Windhorst AD
    Nucl Med Biol; 2013 May; 40(4):488-97. PubMed ID: 23522977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two anti-angiogenic TKI-PET tracers, [(11)C]axitinib and [(11)C]nintedanib: Radiosynthesis, in vivo metabolism and initial biodistribution studies in rodents.
    Slobbe P; Poot AJ; Haumann R; Schuit RC; Windhorst AD; van Dongen GA
    Nucl Med Biol; 2016 Oct; 43(10):612-24. PubMed ID: 27497236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
    Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
    Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma.
    Muselaers CH; Stillebroer AB; Desar IM; Boers-Sonderen MJ; van Herpen CM; de Weijert MC; Langenhuijsen JF; Oosterwijk E; Leenders WP; Boerman OC; Mulders PF; Oyen WJ
    J Nucl Med; 2014 Feb; 55(2):242-7. PubMed ID: 24396030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynthesis and biological evaluation of N-(2-[
    Tang C; Nie D; Tang G; Gao S; Liu S; Wen F; Tang X
    Nucl Med Biol; 2017 Jul; 50():39-46. PubMed ID: 28456080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
    J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of [
    Carlucci G; Carney B; Sadique A; Vansteene A; Tang J; Reiner T
    Nucl Med Biol; 2017 May; 48():9-15. PubMed ID: 28157626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
    Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.
    Rbah-Vidal L; Vidal A; Besse S; Cachin F; Bonnet M; Audin L; Askienazy S; Dollé F; Degoul F; Miot-Noirault E; Moins N; Auzeloux P; Chezal JM
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1449-61. PubMed ID: 22707183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-11C-methyl-L-cysteine: a new amino acid PET tracer for cancer imaging.
    Deng H; Tang X; Wang H; Tang G; Wen F; Shi X; Yi C; Wu K; Meng Q
    J Nucl Med; 2011 Feb; 52(2):287-93. PubMed ID: 21233188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and biological evaluation of 5-(3-[18F]fluoropropyloxy)-L-tryptophan for tumor PET imaging.
    He S; Tang G; Hu K; Wang H; Wang S; Huang T; Liang X; Tang X
    Nucl Med Biol; 2013 Aug; 40(6):801-7. PubMed ID: 23791401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
    Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
    Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and preclinical evaluation of [(11)C]PAQ as a PET imaging tracer for VEGFR-2.
    Samén E; Thorell JO; Lu L; Tegnebratt T; Holmgren L; Stone-Elander S
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1283-95. PubMed ID: 19288096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of
    Roxin Á; Zhang C; Huh S; Lepage ML; Zhang Z; Lin KS; Bénard F; Perrin DM
    Nucl Med Biol; 2018 Jun; 61():11-20. PubMed ID: 29597141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and rapid radiosynthesis of N-
    Sun A; Liu S; Tang X; Nie D; Tang G; Zhang Z; Wen F; Wang X
    Nucl Med Biol; 2017 Jun; 49():38-43. PubMed ID: 28301817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy.
    Katz SI; Zhou L; Ferrara TA; Wang W; Mayes PA; Smith CD; El-Deiry WS
    Int J Oncol; 2011 Jul; 39(1):91-100. PubMed ID: 21537838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.